TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A Being Patient interview with University of British Columbia researcher Dr. Cheryl Wellington discusses how cholesterol in the blood and brain may affect neurological health. Wellington said high LDL in midlife is associated with a 7% to 9% increase in Alzheimer’s disease and related dementia risk, but the interview does not establish that lowering LDL prevents dementia for an individual.
Being Patient has published an interview with University of British Columbia researcher Dr. Cheryl Wellington about how cholesterol may affect brain health and Alzheimer’s disease risk. Wellington said high LDL cholesterol in midlife is linked to an estimated 7% to 9% higher risk of Alzheimer’s disease and related dementias, while stressing that cholesterol in the blood and cholesterol within the brain are distinct.
Wellington, a professor and vice chair of research in the University of British Columbia’s Department of Pathology and Laboratory Medicine, studies cholesterol and proteins that transport it, including ApoE. In the interview, she described the blood-brain barrier as a protective boundary that limits exchange between the bloodstream and the brain. Cholesterol in the blood does not freely cross that barrier, she said, but blood-vessel health and processes inside the brain can both affect neurological health.
Wellington said elevated LDL in midlife is associated with an estimated 7% to 9% increase in risk of Alzheimer’s disease and related dementias. The interview presents this as a risk estimate, not a guarantee that a person with high LDL will develop dementia. It does not specify the underlying study, the population used to calculate the figure, or the time period over which risk was measured.
She also discussed two different kinds of plaque. Atherosclerotic plaque can build up in blood vessels and affect circulation; amyloid plaques in the brain contain amyloid-beta, a protein naturally produced there. Wellington said brain blood vessels and drainage pathways help clear waste products, including amyloid-beta, and that cholesterol-related processes may affect this system. These are explanations of possible mechanisms, not proof that cholesterol alone causes Alzheimer’s disease.
How LDL May Affect Brain Risk
The discussion matters because cholesterol is usually considered in relation to heart and blood-vessel health, while dementia risk develops across many years and has multiple influences. The interview connects these areas: vascular disease may affect the brain’s blood supply, while cholesterol handling within brain cells may also play a role. That distinction cautions against treating a blood cholesterol test as a direct measure of cholesterol in the brain.
Wellington argued that addressing elevated LDL in midlife may matter more than waiting until cognitive symptoms appear. However, the material provided does not show that cholesterol-lowering treatment prevents Alzheimer’s or quantify how much a person’s risk would change with treatment. It supports discussing cholesterol results and personal risk with a qualified health professional, rather than making treatment decisions from the interview alone.
Products Worth Considering
Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking
Therabody Theragun Mini 3rd Gen Massage Gun (Travel Essential, Black)
Garmin Forerunner 70 GPS Running Smartwatch, 43 mm, Black
As an affiliate, we earn on qualifying purchases.
Blood Cholesterol and the Brain
The blood-brain barrier separates much of the brain’s internal environment from substances circulating in the blood. As Wellington explained, cholesterol does not readily cross this barrier, so the brain also has its own cholesterol processes. The brain’s blood vessels remain relevant: cholesterol-related atherosclerosis can impair vessels, and vascular problems can occur alongside Alzheimer’s-related changes.
The interview also raises ApoE4, a gene variant associated with Alzheimer’s risk. Wellington discussed the possibility that cholesterol buildup in brain immune cells may contribute to inflammation, particularly among people carrying ApoE4. The supplied report excerpt does not provide study details or quantify this effect, so it should be understood as a research area discussed in the interview, not a settled explanation of disease.
“Especially in people’s midlife years, high LDL increases the risk of Alzheimer’s disease and related dementias, estimated by about 7 to 9 percent.”
— Dr. Cheryl Wellington, University of British Columbia
Limits of the Risk Estimate
The interview excerpt does not identify the studies behind the 7% to 9% estimate, clarify whether it refers to relative or absolute risk, or specify the population and follow-up period. It also does not establish that lowering LDL directly prevents Alzheimer’s disease, or explain the size of any potential benefit for an individual.
The proposed links involving amyloid-beta clearance, brain immune cells, inflammation and ApoE4 remain mechanisms discussed by Wellington; the supplied material does not provide evidence sufficient to establish how strongly each contributes to disease. Alzheimer’s risk is multifactorial, and the interview does not offer a personal risk assessment or treatment guidance.
Research and Clinical Discussion
The report describes an ongoing research question rather than announcing a new trial, guideline or treatment. Further evidence would be needed to clarify how blood LDL relates to dementia risk across different ages and populations, and whether lowering LDL changes that risk independently of its established relevance to cardiovascular health.
For readers concerned about cholesterol, the practical next step is to review their results and overall health with a qualified clinician. The interview does not recommend a particular medication or target level for dementia prevention. Future research may better distinguish vascular effects from cholesterol processes within the brain and test whether timing of cholesterol management changes cognitive outcomes.
Key Questions
Does high LDL mean someone will develop Alzheimer’s?
No. Wellington described high LDL in midlife as being associated with an estimated 7% to 9% higher risk of Alzheimer’s disease and related dementias. That is a population-level risk estimate, not a prediction for any one person.
Does blood cholesterol enter the brain?
Wellington said cholesterol does not readily cross the blood-brain barrier. Blood cholesterol and cholesterol inside the brain are distinct, although blood-vessel health and brain cholesterol processes may both affect neurological health.
Does lowering LDL prevent Alzheimer’s?
The interview does not establish that lowering LDL prevents Alzheimer’s disease. Wellington said bringing LDL into range may reduce dementia risk, but the supplied material does not explain the evidence or quantify a treatment effect. Discuss cholesterol management with a qualified health professional.
What role might ApoE4 play?
Wellington discussed research suggesting cholesterol buildup in brain immune cells may contribute to inflammation, particularly in people with the ApoE4 variant. The supplied report does not establish the size or certainty of that effect.
Source: beingpatient.com
